scholarly journals Management of Unilateral Masseter Hypertrophy and Hypertrophic Scar—A Case Report

2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Naresh Shetty ◽  
Rajanikanth K. Malaviya ◽  
M. K. Gupta
Keyword(s):  
Case Report ◽  
Hypertrophic Scar ◽  
Masseter Muscle ◽  
Muscle Hypertrophy ◽  
Treatment Options ◽  
Facial Asymmetry ◽  
Rare Condition ◽  
Keloid Scar ◽  
Masseter Muscles ◽  
Single Approach

Masseter muscle hypertrophy is a rare condition of idiopathic cause. It clinically presents as an enlargement of one or both masseter muscles. Most patients complain of facial asymmetry; however, symptoms such as trismus, protrusion, and bruxism may also occur. Several treatment options reported for masseter hypertrophy are present, which range from simple pharmacotherapy to more invasive surgical reduction. Keloid scar with unilateral masseter hypertrophy is a rarely seen in clinical practice. This paper reports a case of unilateral masseter hypertrophy with keloid scar in the angle of the mandible for which surgical treatment was rendered to the patient by using a single approach.

scholarly journals Management of Acquired Bilateral Masseteric Hypertrophy-A Case Report

2015 ◽  
Vol 9 (2) ◽  
pp. 92-95
Author(s):  
S Yadav ◽  
V Dhupar ◽  
A Dhupar ◽  
F Akkara ◽  
HC Mittal
Keyword(s):  
Case Report ◽  
Masseter Muscle ◽  
Muscle Hypertrophy ◽  
Case Reports ◽  
Treatment Options ◽  
Young Male ◽  
Rare Condition ◽  
Mandibular Angle ◽  
Square Configuration ◽  
Prominent Mandibular Angle

ABSTRACT Masseter muscle hypertrophy is a rare condition of unknown cause, which is important due to growing cosmetic concern. A hypertrophied masseter may cause prominent mandibular angle, alter facial lines and characteristic square configuration of face, which may be unacceptable to the patient. Several treatment options reported for masseter hypertrophy, which range from conservative treatment options to invasive surgical procedure. The botulinum therapy offers good results but it's expensive and requires repeated injections with the chances of antibodies development. However, surgical treatment though invasive provides quick and permanent treatment for masseter muscle hypertrophy. The present case reports surgical management of young male patient with masseter hypertrophy due to cosmetic reasons.

Masseter muscle hypertrophy: A case report

2019 ◽  
Vol 31 (6) ◽  
pp. 428-431
Author(s):  
Masayuki Tsuneki ◽  
Satoshi Maruyama ◽  
Manabu Yamazaki ◽  
Kanae Niimi ◽  
Tadaharu Kobayashi ◽  
...  
Keyword(s):  
Case Report ◽  
Masseter Muscle ◽  
Muscle Hypertrophy

scholarly journals Case Report of Idiopathic Masseteric Hypoplasia Treated With PMMA-Collagen Gel

2021 ◽  
Author(s):  
Brian Windle
Keyword(s):  
Masseter Muscle ◽  
Collagen Gel ◽  
Facial Asymmetry ◽  
Rare Condition ◽  
Mental Foramen ◽  
Surgical Correction ◽  
Surgical Approaches ◽  
Gonial Angle ◽  
Malformation Syndromes

Abstract Congenital hypoplasia of the masseter muscle is a rare condition most commonly associated with craniofacial or poly-malformation syndromes, with a small number of reported idiopathic cases. The condition is most commonly managed by orthodonture and later surgical intervention; however, surgery is not an option for all patients. Non-surgical approaches to correcting asymmetry may be considered for patients for whom the functional impact of hypoplasia has been largely managed and the patient’s concern is primarily aesthetic. In this case study, the patient presented for a consultation seeking a non-surgical solution for marked facial asymmetry. The patient underwent physical examination and magnetic resonance imaging to confirm diagnosis of congenital masseter muscle hypoplasia. To treat the asymmetry, a total of 9.6 cc of PMMA-collagen gel (Bellafill ®; Suneva Medical, Inc., San Diego, CA) was injected along the border of the mandible from the gonial angle out to the area of the mental foramen and slightly above over the course of 6 months (2 visits spaced 3 months apart) to provide long-term, non-surgical correction. The patient was very satisfied with the results, highlighting the potential for PMMA-collagen gel to be used in clinical situations in which durable, non-surgical correction of lower-face asymmetry is needed.

scholarly journals Extended effect after a single dose of type A botulinum toxin for asymmetric masseter muscle hypertrophy

2015 ◽  
Vol 48 (02) ◽  
pp. 196-199 ◽  
Author(s):  
Kasturi Bhattacharjee ◽  
Manpreet Singh ◽  
Harsha Bhattacharjee
Keyword(s):  
Botulinum Toxin ◽  
Masseter Muscle ◽  
Muscle Hypertrophy ◽  
Facial Asymmetry ◽  
Type A ◽  
Safe Zone ◽  
Post Injection ◽  
Lower Face ◽  
Facial Contour ◽  
Indian Male

ABSTRACTFacial asymmetry can either be physiological or pathological and is a common cosmetic concern. A 35-year-old Indian male presented with broad appearing lower face and prominent left jaw since adolescence. Parotid enlargement and other local disorders were ruled out. Ultrasonographic thickness of right masseter muscle was 13 mm while that of left was 14.9 mm, in unclenched state. Type-A botulinum toxin (T-ABT) was injected, evenly at five points, in both muscles within the “safe zone”. Using a 29 gauge needle, 15 and 25 international units were delivered to right and left masseters, respectively. Six months post — injection, a reduction of 2.9 mm and 4.4 mm was observed along with a reduced external facial asymmetry. At 24 months, patient maintains a satisfactory facial contour with no significant early or late post-injection complications. Intra-massteric injection of T-ABT can be used effectively as a primary or adjunct procedure for holistic oculo-facial sculpting.

scholarly journals Masseter muscle hypertrophy: case report

2006 ◽  
Vol 17 (4) ◽  
pp. 347-350 ◽  
Author(s):  
Eduardo Kazuo Sannomya ◽  
Marcelo Gonçalves ◽  
Marcelo Paraíso Cavalcanti
Keyword(s):  
Magnetic Resonance Imaging ◽  
Computed Tomography ◽  
Masseter Muscle ◽  
Muscle Hypertrophy ◽  
Mouth Opening ◽  
Conventional Radiography ◽  
Dental Infection ◽  
Resonance Imaging ◽  
Males And Females ◽  
Masseter Muscles

Masseter muscle hypertrophy is characterized by unilateral or bilateral enlargement of the masseter muscles affecting both males and females after puberty. Its etiology remains unknown. Limitations on mouth opening and also tension in the region of the hypertrophied muscle are symptoms reported. This paper reports a case of masseter muscle hypertrophy diagnosed using imaging modalities such as conventional radiography, computed tomography and magnetic resonance imaging scans. The familiarity with this condition is important to settle the differential diagnosis with other pathologies such as parotid gland tumors and dental infection.

scholarly journals Severe Pneumonia in Neonates Associated with Legionella pneumophila: Case Report and Review of the Literature

Pathogens ◽  
2021 ◽  
Vol 10 (8) ◽  
pp. 1031
Author(s):  
Alba Perez Ortiz ◽  
Camilla Hahn ◽  
Thomas Schaible ◽  
Neysan Rafat ◽  
Bettina Lange
Keyword(s):  
Case Report ◽  
Legionella Pneumophila ◽  
Disease Surveillance ◽  
Treatment Options ◽  
Fatal Case ◽  
Severe Pneumonia ◽  
Febrile Illness ◽  
Rare Condition ◽  
Review Of The Literature ◽  
Robert Koch Institute

The causative agent of legionellosis is the Gram-negative intracellular bacteria Legionella spp. Its clinical presentation varies from a mild febrile illness called Pontiac fever to the severe and possible fatal pneumonia, Legionnaires’ disease. Immunocompromised patients, in particular, are affected. Only a small number of infected neonates are described in the literature. Most of them have been associated with water birth or the use of air humidifiers. In the last five years, a growing number of cases have been reported in Germany by the national institute of disease surveillance and prevention (Robert-Koch Institute). Here, we describe a fatal case report of pulmonary legionellosis with acute respiratory distress syndrome (ARDS), sepsis, associated cutaneous manifestation, and extracorporeal membrane oxygenation in a full-term neonate (GA 39+3). Moreover, we present a review of the literature discussing the epidemiology, risk factors, clinical features, diagnostics, treatment options, and prevention for this rare condition in neonates.

scholarly journals Case Report and Literature Review: COVID-19 and status epilepticus in Dyke-Davidoff-Masson syndrome

F1000Research ◽  
2021 ◽  
Vol 10 ◽  
pp. 9
Author(s):  
Lourdes de Fátima Ibañez Valdés ◽  
Jerry Geroge ◽  
Sibi Joseph ◽  
Mohamed Alshmandi ◽  
Wendy Makaleni ◽  
...  
Keyword(s):  
Case Report ◽  
Status Epilepticus ◽  
Medical Literature ◽  
Academic Career ◽  
Cerebral Atrophy ◽  
Facial Asymmetry ◽  
Rare Condition ◽  
High Functioning ◽  
Radiological Features ◽  
First Case

Dyke-Davidoff-Masson syndrome (DMMS) is a non-inherited rare condition with a clinical constellation of hemiparesis/hemiplegia, facial asymmetry, intellectual disability, and epilepsy. The radiological features can be including unilateral cerebral atrophy, calvarial thickening, and hyper pneumatization of the paranasal sinuses. The condition can either be congenital or acquired. The presentation usually occurs during childhood or early adolescents, but there have been adult cases reported. Here we report a 48-year-old male who was a known poorly controlled epileptic that contracted SARS-CoV-2 with subsequently developed status epilepticus and, when worked up, was shown to have features of DDMS. This case is unique as the patient had hemiatrophy and epilepsy but managed to lead a normal, physically demanding, and high functioning academic career and presented late in life. Perhaps only due to coronavirus disease 2019 (COVID-19) was this diagnosis picked up. This report contains a case presenting atypical DDMS in status epilepticus and COVID -19 plus other complications. From our knowledge, this is the first case presenting these comorbidities reported to the medical literature.

scholarly journals Successful Use of the 308-nm Excimer Laser in Early Patch Stage Mycosis Fungoides

2019 ◽  
Vol 10 (3) ◽  
pp. 251-253
Author(s):  
Andrew M. Armenta ◽  
Krystal M. Jones ◽  
Jason S. Reichenberg
Keyword(s):  
Case Report ◽  
Skin Cancer ◽  
Mycosis Fungoides ◽  
Excimer Laser ◽  
Early Stage ◽  
Treatment Options ◽  
Rare Condition ◽  
Dysplastic Nevi ◽  
Increased Risk ◽  
History Of

Introduction: Mycosis fungoides (MF), a type of cutaneous T-cell lymphoma, is a rare condition with a variety of treatment options. A frequently utilized method in the treatment of early-stage MF is phototherapy. Full body phototherapy can be associated with photoaging of the skin and an increased risk of developing skin cancer. Targeted phototherapy, with a 308-nm excimer laser, may be just as effective and of a lower risk. This makes it especially useful in the treatment of patients with dysplastic nevi (DN) or other conditions which can put them at a higher risk of developing skin cancer. There are currently limited data on the treatment of early-stage MF with an excimer laser. Case Report: This study reports on a 43-year-old female patient presented to the clinic with early-stage (Ia) MF. Given her history of DN, she wished to pursue targeted phototherapy with an excimer laser. Localized light treatment was performed via a 308-nm excimer laser, 3 times weekly, for a total of 17 treatments to affected lesions. Following excimer laser treatment, she had a clinical resolution of her patches. On the follow-up clinic visits, she maintained her excellent response 12 months out. Conclusion: Targeted phototherapy with a 308-nm excimer laser may be a safer and equally effective alternative to generalized phototherapy in the treatment of early-stage MF. This case report demonstrates its efficacy and advantages over traditional generalized phototherapy.

Sign in / Sign up

Export Citation Format

Share Document